American Heart Journal
Volume 147, Issue 1 , Pages 42-48 , January 2004

Elevated leukocyte count and adverse hospital events in patients with acute coronary syndromes: findings from the Global Registry of Acute Coronary Events (GRACE)

  • Mark I Furman, MD, FACC

      Affiliations

    • University of Massachusetts Medical School, Worcester, Mass, USA
    • Corresponding Author InformationReprint requests: Mark I. Furman, MD, FACC, Division of Cardiovascular Medicine, University of Massachusetts Medical School, 55 Lake Avenue N, Worcester, MA, 01655, USA.
    • ,
  • Joel M Gore, MD

      Affiliations

    • University of Massachusetts Medical School, Worcester, Mass, USA
    • ,
  • Fredrick A Anderson, PhD

      Affiliations

    • University of Massachusetts Medical School, Worcester, Mass, USA
    • ,
  • Andrzej Budaj, MD, PhD

      Affiliations

    • Grochowski Hospital, Warsaw, Poland
    • ,
  • Shaun G Goodman, MD

      Affiliations

    • Canadian Heart Research Centre and Terrence Donnelly Heart Centre, Division of Cardiology, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Ávaro Avezum, MD

      Affiliations

    • CTI-A Hospital Albert Einstein, São Paulo, Brazil
    • ,
  • José López-Sendón, MD

      Affiliations

    • Hospital Universitario Gregorio Marañon, Madrid, Spain
    • ,
  • Werner Klein, MD

      Affiliations

    • Medizinische Universitätsklinik, Klinische Abteilung für Kardiologi, Graz, Austria
    • ,
  • Debabrata Mukherjee, MD

      Affiliations

    • University of Michigan Health System, Ann Arbor, Mich, USA
    • ,
  • Kim A Eagle, MD

      Affiliations

    • University of Michigan Health System, Ann Arbor, Mich, USA
    • ,
  • Omar H Dabbous, MD, MPH

      Affiliations

    • University of Massachusetts Medical School, Worcester, Mass, USA
    • ,
  • Robert J Goldberg, MD

      Affiliations

    • University of Massachusetts Medical School, Worcester, Mass, USA
    • ,
  • GRACE Investigators

      Affiliations

Received 7 March 2003 ,Accepted 15 July 2003.

References 

  1. Ross R. Atherosclerosis—an inflammatory disease. N Engl J Med. 1999;340:115–126
  2. Danesh J, Collins R, Appleby P, et al.  Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease (meta-analyses of prospective studies). JAMA. 1998;279:1477–1482
  3. Ridker PM, Cushman M, Stampfer MJ, et al.  Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336:973–979
  4. Liuzzo G, Biasucci LM, Gallimore JR, et al.  The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med. 1994;331:417–424
  5. Toss H, Lindahl B, Siegbahn A, et al.  Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. FRISC Study Group (Fragmin during Instability in Coronary Artery Disease). Circulation. 1997;96:4204–4210
  6. Lindahl B, Toss H, Siegbahn A, et al.  Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group (Fragmin during Instability in Coronary Artery Disease). N Engl J Med. 2000;343:1139–1147
  7. Blankenberg S, Rupprecht HJ, Bickel C, et al.  Circulating cell adhesion molecules and death in patients with coronary artery disease. Circulation. 2001;104:1336–1342
  8. Ernst E, Hammerschmidt DE, Bagge U, et al.  Leukocytes and the risk of ischemic diseases. JAMA. 1987;257:2318–2324
  9. van der Wal AC, Becker AE, van der Loos CM, et al.  Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation. 1994;89:36–44
  10. Yarnell JW, Baker IA, Sweetnam PM, et al.  Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease (the Caerphilly and Speedwell collaborative heart disease studies). Circulation. 1991;83:836–844
  11. Friedman GD, Klatsky AL, Siegelaub AB. The leukocyte count as a predictor of myocardial infarction. N Engl J Med. 1974;290:1275–1278
  12. Zalokar JB, Richard JL, Claude JR. Leukocyte count, smoking, and myocardial infarction. N Engl J Med. 1981;304:465–468
  13. Lowe GD, Machado SG, Krol WF, et al.  White blood cell count and haematocrit as predictors of coronary recurrence after myocardial infarction. Thromb Haemost. 1985;54:700–703
  14. Furman MI, Becker RC, Yarzebski J, et al.  Effect of elevated leukocyte count on in-hospital mortality following acute myocardial infarction. Am J Cardiol. 1996;78:945–948
  15. Burr ML, Holliday RM, Fehily AM, et al.  Haematological prognostic indices after myocardial infarction (evidence from the diet and reinfarction trial (DART)). Eur Heart J. 1992;13:166–170
  16. Haines AP, Howarth D, North WR, et al.  Haemostatic variables and the outcome of myocardial infarction. Thromb Haemost. 1983;50:800–803
  17. Barron HV, Harr SD, Radford MJ, et al.  The association between white blood cell count and acute myocardial infarction mortality in patients ≥65 years of age (findings from the cooperative cardiovascular project). J Am Coll Cardiol. 2001;38:1654–1661
  18. Barron HV, Cannon CP, Murphy SA, et al.  Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction (a thrombolysis in myocardial infarction 10 substudy). Circulation. 2000;102:2329–2334
  19. Kyne L, Hausdorff JM, Knight E, et al.  Neutrophilia and congestive heart failure after acute myocardial infarction. Am Heart J. 2000;139:94–100
  20. Maekawa Y, Anzai T, Yoshikawa T, et al.  Prognostic significance of peripheral monocytosis after reperfused acute myocardial infarction (a possible role for left ventricular remodeling). J Am Coll Cardiol. 2002;39:241–246
  21. Rationale and design of the GRACE (Global Registry of Acute Coronary Events) Project: a multinational registry of patients hospitalized with acute coronary syndromes. Am Heart J 2001;141:190–9
  22. Steg PG, Goldberg RJ, Gore JM, et al.  Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE). Am J Cardiol. 2002;90:358–363
  23. Eagle KA, Goodman SG, Avezum A, et al.  Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction (findings from the Global Registry of Acute Coronary Events (GRACE)). Lancet. 2002;359:373–377
  24. Fuster V, Lewis A. Conner Memorial Lecture (mechanisms leading to myocardial infarction: insights from studies of vascular biology). Circulation. 1994;90:2126–2146
  25. Nurden AT, Macchi L, Bihour C, et al.  Markers of platelet activation in coronary heart disease patients. Eur J Clin Invest. 1994;24(Suppl 1):42–45
  26. Blake GJ, Ridker PM. Novel clinical markers of vascular wall inflammation. Circ Res. 2001;89:763–771
  27. Furman MI, Benoit SE, Barnard MR, et al.  Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease. J Am Coll Cardiol. 1998;31:352–358
  28. Ott I, Neumann FJ, Gawaz M, et al.  Increased neutrophil-platelet adhesion in patients with unstable angina. Circulation. 1996;94:1239–1246
  29. Furman MI, Kereiakes DJ, Krueger LA, et al.  Leukocyte-platelet aggregation, platelet surface P-selectin, and platelet surface glycoprotein IIIa after percutaneous coronary intervention (effects of dalteparin or unfractionated heparin in combination with abciximab). Am Heart J. 2001;142:790–798
  30. Neumann FJ, Marx N, Gawaz M, et al.  Induction of cytokine expression in leukocytes by binding of thrombin-stimulated platelets. Circulation. 1997;95:2387–2394
  31. Furman MI, Barnard MR, Krueger LA, et al.  Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction. J Am Coll Cardiol. 2001;38:1002–1006
  32. Michelson AD, Barnard MR, Krueger LA, et al.  Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin (studies in baboons, human coronary intervention, and human acute myocardial infarction). Circulation. 2001;104:1533–1537
  33. Mickelson JK, Lakkis NM, Villarreal-Levy G, et al.  Leukocyte activation with platelet adhesion after coronary angioplasty (a mechanism for recurrent disease?). J Am Coll Cardiol. 1996;28:345–353
  34. Cannon CP, McCabe CH, Wilcox RG, et al.  Association of white blood cell count with increased mortality in acute myocardial infarction and unstable angina pectoris (OPUS-TIMI 16 Investigators). Am J Cardiol. 2001;87:636–639 , A10
  35. Zouridakis EG, Garcia-Moll X, Kaski JC. Usefulness of the blood lymphocyte count in predicting recurrent instability and death in patients with unstable angina pectoris. Am J Cardiol. 2000;86:449–451
  36. Lloyd-Jones DM, Camargo CA, Giugliano RP, et al.  Effect of leukocytosis at initial examination on prognosis in patients with primary unstable angina. Am Heart J. 2000;139:867–873
  37. Entman ML, Smith CW. Postreperfusion inflammation (a model for reaction to injury in cardiovascular disease). Cardiovasc Res. 1994;28:1301–1311
  38. Kristensen SD, Ravn HB, Falk E. Insights into the pathophysiology of unstable coronary artery disease. Am J Cardiol. 1997;80:5–9E
  39. Sharma R, Anker SD. Immune and neurohormonal pathways in chronic heart failure. Congest Heart Fail. 2002;8:23–28 , 48
  40. Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res. 2002;53:31–47

☆ The GRACE project is supported by an unrestricted educational grant from Aventis Pharma (Bridgewater, NJ).Guest Editor for this manuscript was Raymond J. Gibbons, MD, Mayo Clinic, Rochester, Minn.

PII: S0002-8703(03)00592-1

doi: 10.1016/j.ahj.2003.07.003

American Heart Journal
Volume 147, Issue 1 , Pages 42-48 , January 2004

Article Tools

* Image Usage & Resolution